Finance

Lists
Why is NVCT down 2,40%?
Dive Deeper
NVCT:NASDAQ
Nuvectis Pharma Inc
20,31 $
-2,40%
(-0,50) 1D
29 սեպ, 11:09:21 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCT...
Open
20,91 $
High
21,40 $
Low
20,25 $
Mkt. cap
661,73 մլն
Avg. vol.
218,46 հզր
Volume
20,87 հզր
52-wk high
29,28 $
52-wk low
5,55 $
EPS
-1,31 $
Beta
-0,26
Shares outstanding
32,64 մլն
No. of employees
16
Open
20,91 $
High
21,40 $
Low
20,25 $
Mkt. cap
661,73 մլն
Avg. vol.
218,46 հզր
Volume
20,87 հզր
52-wk high
29,28 $
52-wk low
5,55 $
EPS
-1,31 $
Beta
-0,26
Shares outstanding
32,64 մլն
No. of employees
16
About Nuvectis Pharma Inc
CEO-
Employees16
Founded2020
HeadquartersFort Lee, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to NVCT in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NVCT in the last 3 months.
Highest
Current 20,31 $
39,00 $ (+92,02%)
Average
34,00 $ (+67,41%)
Lowest
30,00 $ (+47,71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
30,00 $
+47,7%
09/25/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
39,00 $
+92%
09/24/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
-
-
08/24/2026
Christopher Liu
Lucid Capital
Buy
Maintained
34,00 $
+67,4%
08/05/2026
Jonathan Aschoff
Roth MKM
Buy
Reiterated
33,00 $
+62,5%
07/06/2026
Unknown Analyst
Roth MKM
Buy
Maintained
20,00 $
-1,5%
06/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,77 մլն
5,09 մլն
4,11 մլն
4,68 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,02 մլն
2,53 մլն
2,15 մլն
2,51 մլն
Operating expense
7,79 մլն
7,62 մլն
6,26 մլն
7,20 մլն
Total operating expenses
7,79 մլն
7,62 մլն
6,26 մլն
7,20 մլն
Operating income
-7,79 մլն
-7,62 մլն
-6,26 մլն
-7,20 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-7,46 մլն
-7,31 մլն
-6,05 մլն
-7,02 մլն
EBT excluding unusual items
-7,46 մլն
-7,31 մլն
-6,05 մլն
-7,02 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,46 մլն
-7,31 մլն
-6,05 մլն
-7,02 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
332,00 հզր
303,00 հզր
210,00 հզր
177,00 հզր
Interest expense
-
-
-
-
Net interest expenses
332,00 հզր
303,00 հզր
210,00 հզր
177,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps